Abstract
Lung cancer is the second most diagnosed type of cancer worldwide and the most lethal, accounting for 18% of all cancer deaths in 2020. Although chemotherapy is widely used in treatment, variability in patient responses to the same treatment remains a significant challenge. One reason for this variability is the difference in tumor transcriptional profiles among patients. Studies have com…